Today's Two Stealth Growth Ideas 06/08

In today's issue of Stealth Growth Insider we've highlighted one company with an expanding pipeline and acquisition synergies to be absorbed and one rapid growth company that could benefit from reduced GDP growth yet still has excess capacity to expand.

Mylan (NYSE: MYL) - Epipen competitor, Adamis, received a second CRL letter from the FDA and the Meda acquisition appears to be on track to close in 3Q.

QTS Realty Trust (NYSE: QTS) - QTS is an emerging data center REIT at the center of the datacenter/cloud outsourcing trend.

See the entire issue below (or click here for some browsers)

*** Subscribe to receive the daily Stealth Growth Insider newsletter completely FREE for a limited time. Sign-up FREE here.

You May Also Be Interested In

• GameSquare Holdings Inc (GAME) PT Lowered to $5 at Roth/MKM
• Vertex (VERX) Announces Pricing of Upsized $300 Mln Convertible Senior Notes Offering
• Advent Technologies (ADN) Receives Nasdaq Notice on Late Filing of its Form 10-K